ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CYAD Celyad Oncology SA

0.47
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Celyad Oncology SA CYAD NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.47 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.47 0.47
more quote information »

Recent News

Date Time Source Heading
04/4/202416:00BWCelyad Oncology publie ses résultats financiers pour l'année..
09/2/202408:01BWCelyad Oncology annonce son intention de mettre fin à ses..
17/1/202422:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202408:01BWCelyad Oncology fait le point sur les activités du quatrième..
21/12/202322:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202308:01BWCelyad Oncology SA : Publication d’une notification de..
16/12/202308:01BWCelyad Oncology: Information on the Total Number of Voting..
05/12/202300:34BWCelyad annonce un changement de direction
01/12/202308:01BWCelyad Oncology SA : Publication d’une notification de..
22/11/202308:00BWCelyad Oncology SA: Publication of a transparency..
16/11/202308:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202308:00BWCelyad Oncology: Information on the Total Number of Voting..
09/11/202317:00BWCelyad Oncology publie ses résultats financiers pour le..
28/10/202304:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202306:01BWCelyad Oncology Announces the Termination of Its American..
18/9/202320:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/9/202306:01BWCelyad Oncology SA: Publication of a Rectified Transparency..
13/9/202320:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/9/202306:01BWCelyad Oncology SA: Publication of a Transparency..
11/9/202320:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/9/202306:01BWCelyad Oncology SA: Publication of a Transparency..
06/9/202320:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/9/202306:00GLOBEInformation on the Total Number of Voting Rights and Shares..
05/9/202320:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202306:00BWCelyad Oncology Présente ses Résultats Financiers pour le..
30/8/202302:00BWCelyad Oncology Receives Approximately EUR 9.8m in Private..
25/8/202320:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/8/202306:00GLOBECelyad Oncology receives approximately EUR 9.8m in private..
16/5/202306:01BWCelyad Oncology annonce la réception d’un avis de radiation..
05/5/202315:44BWCelyad Oncology annonce son intention de radier les American..
05/5/202315:42BWCelyad Oncology publie ses résultats financiers pour le..
05/5/202315:00GLOBECelyad Oncology reports first quarter 2023 financial results..

Your Recent History

Delayed Upgrade Clock